Insider Trading Hints & Signals — September 29, 2026 — After Hours — Last 24 Hours (Pacific Time)

Executive Summary

Insider activity over the past 24 hours is decisively sell-side dominated, with high-profile C-suite executives at major technology and growth companies offloading tens of millions in stock. The standout transaction is GitLab director Sytse Sijbrandij's $101M sale, followed by Meta CEO Mark Zuckerberg's $21.36M disposal and CrowdStrike CEO George Kurtz's $5.16M sale. Buying activity exists but is modest in scale, with the most meaningful purchase signals coming from Inhibrx Biosciences' CEO (~$998K) and Infinity Natural Resources' CFO (~$300K).

Activity Breakdown

Net Signal: 🔴 Bearish — Net selling of approximately $137.1M over the period. Sales dwarf purchases in both count and dollar value.

Note: Ciena director Claflin's $1.02M contribution to an exchange fund is treated as a disposition for tabulation purposes. The C1 Fund CIO purchase is dated December per the context — timing ambiguity noted.

Top Notable Transactions

🔴 GitLab (GTLB) — Signal Strength: Very Strong Bearish

• Insider: Sytse Sijbrandij, Director
• Transaction: Sale of $101M
• Signal: Strong Bearish
• Context: A nine-figure disposal by a director — the single largest transaction in this period — is a significant signal worth watching, even accounting for pre-planned selling programs.

🔴 GitLab (GTLB) — Signal Strength: Strong Bearish (Cluster)

• Insider: Padisetty Sivaprasad, Chief Technology Officer
• Transaction: Sale of $2.38M
• Signal: Strong Bearish
• Context: The CTO selling $2.38M on the same reporting cycle as the director's $101M sale creates a notable cluster sell signal at GitLab.

🔴 Meta Platforms (META) — Signal Strength: Strong Bearish

• Insider: Mark Zuckerberg, Chairman & CEO
• Transaction: Sale of $21.36M
• Signal: Moderate Bearish (Zuckerberg sells regularly via a pre-planned program)
• Context: Continued systematic liquidation by the CEO; while routine, the scale keeps it on the radar.

🔴 CrowdStrike (CRWD) — Signal Strength: Strong Bearish

• Insider: George Kurtz, President & CEO
• Transaction: Sale of $5.16M
• Signal: Moderate Bearish
• Context: CEO-level selling at a high-profile cybersecurity name warrants attention, particularly given the stock's elevated valuation.

🔴 Monopar Therapeutics (MNPR) — Signal Strength: Strong Bearish

• Insider: Chandler Robinson, CEO & Director
• Transaction: Sale of $2.5M
• Signal: Strong Bearish
• Context: A CEO selling $2.5M in a small-cap biotech is a proportionally large disposition that stands out.

🔴 Everpure (P) — Signal Strength: Strong Bearish

• Insider: Ajay Singh, Chief Product Officer
• Transaction: Sale of $5.33M
• Signal: Strong Bearish
• Context: A $5.33M sale by the CPO is a substantial insider exit for this company.

🔴 Hut 8 (HUT) — Signal Strength: Moderate Bearish

• Insider: Mayo A. Shattuck III, Director
• Transaction: Sale of $2M
• Signal: Moderate Bearish
• Context: Director-level selling of $2M in a crypto mining company amid volatile digital asset markets is a cautionary signal.

🔴 Sonos (SONO) — Signal Strength: Moderate Bearish

• Insider: Karen Boone, Director
• Transaction: Sale of $847,636
• Signal: Moderate Bearish
• Context: Director selling nearly $850K in a consumer electronics company already navigating a difficult product cycle.

🔴 Akamai Technologies (AKAM) — Signal Strength: Moderate Bearish

• Insider: Mani Sundaram, EVP & GM of Security
• Transaction: Sale of $882K
• Signal: Moderate Bearish
• Context: A senior executive overseeing Akamai's security division — a key growth engine — liquidating nearly $900K is worth noting.

🔴 Block (XYZ) — Signal Strength: Moderate Bearish

• Insider: Anthony Mathew Eisen, Director
• Transaction: Sale of $1.36M
• Signal: Moderate Bearish
• Context: Director-level selling above $1M at Block adds to the broader sell-side tone in fintech.

🟢 Inhibrx Biosciences (INBX) — Signal Strength: Strong Bullish

• Insider: Mark Lappe, CEO & Director
• Transaction: Purchase of ~$998K
• Signal: Strong Bullish
• Context: A CEO buying nearly $1M of his own company's stock is one of the most credible bullish signals in this entire dataset.

🟢 Infinity Natural Resources (INR) — Signal Strength: Moderate Bullish

• Insider: Cary D. Baetz, EVP & CFO
• Transaction: Purchase of ~$300K
• Signal: Moderate Bullish
• Context: CFO-level open-market buying close to $300K signals confidence in the company's near-term trajectory.

🟢 Hudson Technologies (HDSN) — Signal Strength: Moderate Bullish

• Insider: Hartree Partners LP (Director & 10% Owner)
• Transaction: Purchase of $604K (118,549 shares)
• Signal: Moderate Bullish
• Context: A significant block purchase by a 10% owner and director suggests conviction in Hudson Technologies at current levels.

🟢 Angel Oak Mortgage REIT (AOMR) — Signal Strength: Moderate Bullish

• Insider: Michael Fierman, Director & 10% Owner
• Transaction: Purchase of $290,510
• Signal: Moderate Bullish
• Context: A 10% owner adding nearly $291K in a mortgage REIT environment signals rate-environment confidence.

🟢 Dave & Buster's (PLAY) — Signal Strength: Moderate Bullish

• Insider: Cory Hatton, Interim CFO
• Transaction: Purchase of ~$26K
• Signal: Moderate Bullish
• Context: An interim CFO buying stock — even at a modest level — is a meaningful vote of confidence during a transitional leadership period.

🟢 PIMCO Dynamic Income Fund (PDI) — Signal Strength: Moderate Bullish

• Insider: Alan Rappaport, Director
• Transaction: Purchase of $75,654
• Signal: Moderate Bullish
• Context: Director buying in a closed-end income fund suggests confidence in the fund's yield and NAV stability.

Pattern Analysis

🔴 GitLab (GTLB) — Cluster Selling

• Net Signal: Strong Bearish
• Companies: GitLab (GTLB)
• Total Value: ~$103.38M in sales (Sijbrandij $101M + Sivaprasad $2.38M)
• Two insiders — a director and the CTO — both disposing of stock in the same reporting window is a high-conviction bearish cluster. At this scale, it's the dominant story of the day regardless of pre-planned program considerations.

🔴 Finward Bancorp (FNWD) — Cluster Buying (Small-Scale)

• Net Signal: Mildly Bullish
• Companies: Finward Bancorp (FNWD)
• Total Value: ~$3,693 in purchases (Puntillo $233 + Bochnowski $224 + Lowry $1,829 + Scheub $1,407)
• Four separate insiders — including the CEO, two EVPs, and a director — all acquired shares on the same day. While the dollar amounts are very small, the breadth of participation across the leadership team is a genuine cluster signal.

🔴 BillionToOne (BLLN) — Cluster Selling

• Net Signal: Moderate Bearish
• Companies: BillionToOne (BLLN)
• Total Value: ~$586,545 in sales (ten Bosch $169,920 + Tsao $416,625)
• Both the SVP of Lab Operations and the CTO sold stock in the same reporting cycle — a dual-insider exit at a genomics company worth monitoring.

🔴 Technology Sector — Broad C-Suite Selling

• Net Signal: Bearish
• Companies: GitLab (GTLB), Meta (META), CrowdStrike (CRWD), Akamai (AKAM), Zscaler (ZS), Ambarella (AMBA)
• Total Value: ~$130M+ in tech-sector sales
• C-suite and director selling is concentrated heavily in technology and cybersecurity names, suggesting insiders across the sector may view current valuations as full or elevated.

🟢 Small/Mid-Cap CEO Buying — Conviction Signal

• Net Signal: Bullish
• Companies: Inhibrx Biosciences (INBX), Infinity Natural Resources (INR), Dave & Buster's (PLAY), Dolphin Entertainment (DLPN)
• Total Value: ~$1.33M in purchases
• CEOs and CFOs at smaller companies are putting meaningful personal capital to work, which historically carries more predictive weight than director-level sales.

Sector Breakdown

Technology & Cybersecurity 🔴 (Strong Bearish)

• Net Signal: ~-$132M net selling
• Notable: GitLab (GTLB), Meta (META), CrowdStrike (CRWD), Akamai (AKAM), Zscaler (ZS), Ambarella (AMBA), Block (XYZ)
• Context: Dominant sell-side pressure from C-suite and directors across large and mid-cap tech; GitLab's $101M sale alone skews the entire day's data.

Biotech & Life Sciences 🔴 (Moderate Bearish)

• Net Signal: ~-$3.5M net selling
• Notable: Cytokinetics (CYTK), Monopar Therapeutics (MNPR), Glaukos (GKOS), Revolution Medicines (RVMD)
• Context: Multiple biotech insiders selling, offset partially by Inhibrx Biosciences CEO's near-$1M purchase — the one bright spot in the sector.

Biotech — Bullish Outlier 🟢

• Net Signal: +$998K
• Notable: Inhibrx Biosciences (INBX)
• Context: CEO buying nearly $1M stands out sharply against the sector's sell-side trend.

Energy & Natural Resources 🟢 (Mildly Bullish)

• Net Signal: ~+$132K net buying (INR purchase offset by BKV sale)
• Notable: Infinity Natural Resources (INR), BKV Corp (BKV)
• Context: CFO buying at INR is a positive signal; BKV SVP selling partially offsets.

Financial Services & REITs 🟢 (Mildly Bullish)

• Net Signal: Net positive buying
• Notable: Angel Oak Mortgage REIT (AOMR), Finward Bancorp (FNWD), PIMCO Dynamic Income (PDI), Commercial Bancgroup (CBK)
• Context: Multiple small purchases across banking and REIT names suggest modest insider confidence in financials, particularly in the mortgage/income space.

Crypto & Digital Assets 🔴 (Moderate Bearish)

• Net Signal: -$2M net selling
• Notable: Hut 8 (HUT)
• Context: Director-level selling at a crypto miner adds a cautionary note to the digital asset space.

Consumer & Entertainment 🟡 (Mixed)

• Net Signal: Mixed
• Notable: Dave & Buster's (PLAY — buy), Sonos (SONO — sell), Dolphin Entertainment (DLPN — buy)
• Context: Split signals in consumer; CFO buying at PLAY is a positive amid the company's ongoing turnaround, while Sonos director selling adds pressure to an already challenged name.

Market Implications

The overwhelming takeaway from today's insider activity is that technology insiders — particularly at high-growth, high-valuation names — are aggressively monetizing their positions. GitLab's combined $103M+ in insider sales in a single reporting window is extraordinary and, even if partially pre-planned, reflects a level of insider distribution that the market should not ignore. When you layer in Zuckerberg's $21.36M, Kurtz's $5.16M, and the Akamai and Zscaler CFO/EVP sales, a clear picture emerges: tech insiders broadly appear to view current price levels as favorable exit points.

The biotech and life sciences sector tells a more nuanced story. While several insiders at Cytokinetics, Monopar, Glaukos, and Revolution Medicines are selling, the Inhibrx Biosciences CEO's near-$1M open-market purchase is a meaningful counter-signal. CEO purchases — especially at this scale in a small-cap biotech — are among the most reliable bullish indicators available to retail investors, as executives rarely buy their own stock unless they have genuine conviction.

The one area of consistent, if modest, insider confidence is financials and natural resources. Cluster buying at Finward Bancorp (four insiders), meaningful purchases at Angel Oak Mortgage REIT, Hudson Technologies, and Infinity Natural Resources all point to pockets of insider optimism outside the tech sector. This divergence — selling in tech, buying in financials and energy — may be worth tracking as a potential rotation signal.

Key Takeaways

• 🔴 GitLab (GTLB): Director + CTO sold a combined ~$103.4M — the dominant story of the day and a major cluster sell signal.
• 🔴 Meta (META): Zuckerberg sold $21.36M in another installment of his ongoing systematic liquidation program.
• 🔴 CrowdStrike (CRWD): CEO George Kurtz sold $5.16M — C-suite selling at a premium-valued cybersecurity leader.
• 🔴 Everpure (P): CPO sold $5.33M — a large insider exit worth monitoring for context on company outlook.
• 🔴 Monopar Therapeutics (MNPR): CEO sold $2.5M in a small-cap biotech — proportionally significant and a cautionary signal.
• 🔴 BillionToOne (BLLN): CTO and SVP both sold stock in the same window — a dual-insider cluster sell at a genomics company.
• 🟢 Inhibrx Biosciences (INBX): CEO bought ~$998K — the single most credible bullish signal in today's data; CEO open-market purchases are high-conviction.
• 🟢 Hudson Technologies (HDSN): 10% owner/director bought $604K (118,549 shares) — meaningful block purchase by a major stakeholder.
• 🟢 Finward Bancorp (FNWD): Four insiders — CEO, two EVPs, and a director — all bought shares on the same day; small dollars but broad conviction.
• 🟢 Infinity Natural Resources (INR): CFO bought ~$300K — senior financial officer putting personal capital to work is a bullish signal.
• 🟢 Angel Oak Mortgage REIT (AOMR): 10% owner/director bought $290,510 — signals confidence in mortgage REIT valuations at current rates.
• 🔴 Hut 8 (HUT): Director sold $2M in crypto mining stock — insider caution in digital asset infrastructure.
• 🔴 Today's ratio is decisively bearish: ~25 sell transactions vs. 17 buys, with ~$138.9M in sales vs. ~$1.77M in purchases — a lopsided signal skewed heavily by tech mega-sales.
• 🟡 Sector divergence to watch: Insiders selling aggressively in tech/growth while quietly buying in financials, energy, and select biotech — a potential rotation signal.
• 🔴 Sonos (SONO): Director sold $847,636 — adds insider pressure to an already challenged consumer electronics name.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/